At 19 years old, shortly after moving out of his family home, Cael began experiencing severe anxiety and panic attacks. Seeking help, he turned to his longtime family doctor, who diagnosed him with Generalized Anxiety Disorder (GAD) and prescribed Lexapro. Cael was not informed of the potential risks or side effects. While the medication initially brought relief, it soon led to emotional numbness, social withdrawal, depression, and persistent suicidal thoughts—symptoms he had never experienced before.
Over the next several years, Cael was prescribed multiple psychiatric medications, including Lexapro, Effexor, Zoloft, Pristiq, Seroquel, Mirtazapine, and Cymbalta. With each treatment, his condition worsened. He experienced severe emotional blunting, cognitive difficulties, sexual dysfunction, insomnia, panic attacks, and escalating suicidal ideation. Despite repeatedly reporting these symptoms to medical professionals, his concerns were often dismissed or attributed to underlying mental illness rather than the medications themselves.
At age 21, after discontinuing Zoloft, Cael experienced a prolonged withdrawal syndrome that left him struggling with extreme anxiety and insomnia. Eventually, after taking Cymbalta, he developed severe and persistent sexual dysfunction, genital numbness, emotional numbness, and a profound loss of pleasure in everyday life. A urologist later diagnosed him with Post-SSRI Sexual Dysfunction (PSSD), and he was also diagnosed with idiopathic neuropathy.
Now 23 years old, Cael continues to live with the lasting effects of these medications. His story highlights the challenges faced by individuals who experience serious adverse reactions to psychiatric drugs and underscores the importance of informed consent, patient advocacy, and greater awareness of conditions such as PSSD.